Li, L <br/><br/>
EGFR wild type antagonizes EGFRvIII-mediated activation of Met in glioblastoma.  [electronic resource] 

 -  Oncogene  Jan 2015 
 - 129-134 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1476-5594 
<br/><br/><label>Standard No.: </label>10.1038/onc.2013.534  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Brain Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>Dacarbazine--analogs & derivatives<br/>Epidermal Growth Factor--metabolism<br/>ErbB Receptors--metabolism<br/>Gene Expression Regulation, Neoplastic<br/>Glioblastoma--drug therapy<br/>Humans<br/>Phenotype<br/>Phosphorylation<br/>Proto-Oncogene Proteins c-met--metabolism<br/>Receptor Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Temozolomide